Title: Integrated care group visits: a team approach to treating opioid use disorders
Carrie Anderson, MD (Family Physician) & Stephanie Case, PsyD, HSPP (Psychologist)
Franciscan Health Indianapolis
1st choice: Collaborative and integrated care models and practices
2nd choice: Behavioral Health and Health Behavior Change
Has this presentation been previously presented at another conference? No
- Participants will be able to clearly define the role of each provider in an integrated care group.
- Participants will be able to identify a target population specific to chronic and/or complex illness group in their own clinic.
- Participants will be able to list at least 3 benefits relevant to a patient centered medical home utilizing a team based approach to treatment.
The opioid epidemic is moving much faster than healthcare has been able to meet its demands. The somewhat fragmented traditional method of the primary care physician managing medication assisted treatment, a rehabilitation center handling detox, extended inpatient treatment, or sober living, and long-term community services (e.g., Narcotics Anonymous) have been inadequate when facing a less than linear path of opioid addiction and use. These methods, although important to achieve recovery, might be missing the key component of communication between providers. This communication is necessary to achieve the goals of the patient centered medical home. Our clinic has followed several pilots to treat the whole patient in one location, atone visit, to address various stages of opioid use disorder as a team. The integrated care group visits allow patients to check in with their physician, record vitals, refill prescriptions, and participate in a supportive and educational psychotherapy group. This method has allowed for improved communication and direct participation by mental health professionals, nursing, and physicians during a two in a half hour appointment twice per month. These types of visits remove the barrier of insufficient communication between providers, as each provider participates throughout the encounter. Moreover, the group provides a community in which the patient feels secure revealing relapse and additional need for resources that transcends beyond group visits to specifically target the non-linear path of opioid use and recovery.
This session will first focus on relevant epidemiological evidence for need, other disorders targeted by integrated care groups, and rationale for initiating an integrated care group for opioid use. Second, the session will focus on the methods selected for the specific design to initiate group visits to fit specific populations. Additionally, quantitative and qualitative feedback from patients and providers, medical, and psychological measurements will be presented as evidence for efficacy. Next, the session will provide several guided questions for reflection and discussion. Finally, there will be time left for general questions.